Related references
Note: Only part of the references are listed.Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart Disease
Lutz P. Breitling et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Tobacco-Smoking-Related Differential DNA Methylation: 27K Discovery and Replication
Lutz P. Breitling et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease
Norma Christine Grandi et al.
HEART (2011)
Validated Smoking Cessation and Prognosis in Patients With Stable Coronary Heart Disease
Lutz P. Breitling
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis
Julian Ilcheff Borissoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
Frances Wensley et al.
BRITISH MEDICAL JOURNAL (2011)
Serum Fetuin-A, Cardiovascular Risk Factors, and Six-Year Follow-up Outcome in Patients With Coronary Heart Disease
Marcel Roos et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years
L. P. Breitling et al.
ATHEROSCLEROSIS (2010)
Prognostic value of chronic kidney disease in patients with coronary heart disease: Role of estimating equations
Qiu-Li Zhang et al.
ATHEROSCLEROSIS (2010)
Cholesteryl ester transfer protein in patients with coronary heart disease
Kristina Duwensee et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Epigenetics and cardiovascular disease
Jose M. Ordovas et al.
NATURE REVIEWS CARDIOLOGY (2010)
Genome-scale approaches to the epigenetics of common human disease
Andrew P. Feinberg
VIRCHOWS ARCHIV (2010)
Triggering of Proteinase-Activated Receptor 4 Leads to Joint Pain and Inflammation in Mice
Jason J. McDougall et al.
ARTHRITIS AND RHEUMATISM (2009)
B-Type Natriuretic Peptides and Cardiovascular Risk Systematic Review and Meta-Analysis of 40 Prospective Studies
Emanuele Di Angelantonio et al.
CIRCULATION (2009)
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
Wolfgang Koenig et al.
EUROPEAN HEART JOURNAL (2009)
Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20 000 Dutch men and women aged 20-65 years
Ineke van Dis et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events?
Naveed Sattar et al.
PLOS MEDICINE (2009)
The future of biomarkers in the management of patients with acute coronary syndromes
Michelle O'Donoghue et al.
CURRENT OPINION IN CARDIOLOGY (2008)
How to prevent 100 million deaths from tobacco
Thomas R. Frieden et al.
LANCET (2007)
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease
Dietrich Rothenbacher et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation
Chin-Chung Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Protease-activated receptors in cardiovascular diseases
Andrew J. Leger et al.
CIRCULATION (2006)
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease
M Von Eynatten et al.
CLINICAL CHEMISTRY (2006)
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-Leiden/human C-reactive protein transgenic mice
A Trion et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Shape of the relapse curve and long-term abstinence among untreated smokers
JR Hughes et al.
ADDICTION (2004)